NEW
YORK, Oct. 14, 2024 /PRNewswire/ -- The Gross
Law Firm issues the following notice to shareholders of Outset
Medical, Inc. (NASDAQ: OM).
Shareholders who purchased shares of OM during the class period
listed are encouraged to contact the firm regarding possible lead
plaintiff appointment. Appointment as lead plaintiff is not
required to partake in any recovery.
CONTACT US HERE:
https://securitiesclasslaw.com/securities/outset-medical-loss-submission-form/?id=107875&from=4
CLASS PERIOD: August 1,
2022 to August 7, 2024
ALLEGATIONS: The complaint alleges that
during the class period, Defendants issued materially false and/or
misleading statements and/or failed to disclose that: (1) the Tablo
products, its primary devices used in dialysis care, were marketed
for continuous renal replacement therapy, which is not one of the
indications approved by the FDA; (2) as a result, Outset Medical
was reasonably likely to submit an additional 510(k) application
for the Tablo products; (3) there was a substantial risk that the
Company would cease sales of the Tablo products pending FDA
approval of additional indications; (4) Outset Medical lacked the
sales team and process to execute on the ramp of Tablo sales; (5)
as a result of the foregoing, the Company's revenue growth would be
adversely impacted; and (6) as a result of the foregoing,
defendants' positive statements about the Company's business,
operations, and prospects were materially misleading and/or lacked
a reasonable basis.
DEADLINE: October 28, 2024
Shareholders should not delay in registering for this class action.
Register your information here:
https://securitiesclasslaw.com/securities/outset-medical-loss-submission-form/?id=107875&from=4
NEXT STEPS FOR SHAREHOLDERS: Once you register as a
shareholder who purchased shares of OM during the timeframe listed
above, you will be enrolled in a portfolio monitoring software to
provide you with status updates throughout the lifecycle of the
case. The deadline to seek to be a lead plaintiff is October 28, 2024. There is no cost or obligation
to you to participate in this case.
WHY GROSS LAW FIRM? The Gross Law Firm is a nationally
recognized class action law firm, and our mission is to protect the
rights of all investors who have suffered as a result of deceit,
fraud, and illegal business practices. The Gross Law
Firm is committed to ensuring that companies adhere to responsible
business practices and engage in good corporate citizenship. The
firm seeks recovery on behalf of investors who incurred losses when
false and/or misleading statements or the omission of material
information by a company lead to artificial inflation of the
company's stock. Attorney advertising. Prior results do not
guarantee similar outcomes.
CONTACT:
The Gross Law Firm
15 West 38th Street, 12th floor
New York, NY, 10018
Email: dg@securitiesclasslaw.com
Phone: (646) 453-8903
View original content to download
multimedia:https://www.prnewswire.com/news-releases/the-gross-law-firm-reminds-outset-medical-investors-of-the-pending-class-action-lawsuit-with-a-lead-plaintiff-deadline-of-october-28-2024--om-302274131.html
SOURCE The Gross Law Firm